Category: Rich’s Insider Tracker

Insiders continued to buy at a brisk pace as stocks fall on their face. It was the second week in a row that a long list of corporate insiders bought as Wall Street sold. Last week, we attributed the contrast...

Everybody loves a good sale. Corporate insiders picked up their buying activity as stocks got cracked last week. Last week’s list of buyers was noticeably longer than it’s been for the past month. Growing insider interest doesn’t necessarily mean the...

The market continues to be in a perilous situation, flirting with potentially waterfalling lower. It might not take too much of a push to initiate outsized losses. With the possibility of a crash, we will stick with the theme we’ve...

Last week we talked about identifying industry leaders that are getting trashed as the market falls, especially those with insider buying. We are going to continue with that theme this week. The idea is to compile a list of quality...

To be honest, there isn’t anything on last week’s insider buying roster that made the cut for us. Inozyme Pharma, Inc. (INZY), a startup biotech came close, but the company is a long way from profitability and an approved product....

In boxing, a one-two combination is a jab followed by a cross. In the insider buying ring, our view of a one-two combination is when the Chief Executive Officer (CEO) and the Chief Financial Officer (CFO) buy at the same...

Most of last week’s most notable insider buys were made by institutions. Money managers, hedge funds… need to report their activity if they have or acquire a stake of 10% or more in publicly-traded companies. So, if we are going...

Last week’s Excel spreadsheet of insider buys was a little bit shorter than the previous week’s number of rows. Maybe, the stock market’s aggressive rebound spooked some potential purchasers back to the sidelines. Whatever the reason for the pause, it...